BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2012
View Archived Issues
Kyowa Hakko Kirin reviews accomplishments of 2011
Read More
RNA-loaded dendritic cell vaccine shows promise combined with sunitinib
Read More
EpiCept seeks fast track designation for AmiKet
Read More
African sleeping sickness drug shows potential to treat leishmaniasis
Read More
Foretinib shows promise in large papillary renal cell carcinoma study
Read More
New vaccines for human papillomavirus prepared in China
Read More
Artificial Cell Technologies patents novel RSV vaccines
Read More
New phase I safety data presented on stroke therapy
Read More
Scientists at Calmune prepare novel antibodies for RSV infection
Read More
Bradykinin B1 receptor antagonist reduces pain in vivo
Read More
Vertex Pharmaceuticals claims novel HCV NS5B inhibitors
Read More
Rib-X Pharmaceuticals receives milestone payment under RX-04 collaboration
Read More
Amicus receives grant for Pompe's disease program
Read More
Japanese authorities remove condition for approval of Tarceva in NSCLC
Read More
Merck & Co. recaps milestones of fourth quarter and full year 2011
Read More
Erivedge launched in U.S.
Read More
Alexion Pharmaceuticals completes acquisition
Read More
FDA sets date for crofelemer NDA
Read More
Phase II study of ziprasidone commences in Japan
Read More
Line extension for Vyvanse in U.S.
Read More
Omeros provides update on phase III OMS-302 trial
Read More
Bio-Path completes treatment of second cohort in BP-100-1.01 study
Read More
Health Canada approves ipilimumab
Read More
FDA grants priority review for pertuzumab
Read More
Orion plans new studies of inhalable budesonide/formoterol combination
Read More